Your browser doesn't support javascript.
loading
Economic evaluation of snake antivenom production in the public system
Morais, V; Massaldi, H.
Affiliation
  • Morais, V; Universidad de la República. Facultad de Medicina. Departamento de Desarrollo Biotecnológico y Producción. Montevideo. UY
  • Massaldi, H; Universidad de la República. Facultad de Medicina. Departamento de Desarrollo Biotecnológico y Producción. Montevideo. UY
J. venom. anim. toxins incl. trop. dis ; 12(3): 497-511, 2006. tab
Article in En | LILACS | ID: lil-439144
Responsible library: BR33.1
ABSTRACT
Snake antivenom, an expensive animal product, is presently the only effective treatment for the consequences of snakebite. In Latin America, antivenoms are mainly produced by public institutions with frequent shortages of the necessary supply. Here, we present an economical analysis of the factors affecting production cost, assuming a basic processing batch of 100 L hyperimmune plasma. Three annual production volumes were considered for two typical production technologies. The components of cost were classified as fixed, variable and semi-variable. We found that in all stages of production, fixed cost represents the major contribution to total cost, and is given essentially by manpower cost, particularly for low production volumes. Our estimation shows that antivenom cost can vary from US$ 2.4 to US$ 25 per 10 mL vial, depending on the production volume, the plasma processing technology used and the titer achieved during the immunization stage. We conclude that interested laboratories and authorities of countries with population at risk should consider the possibility of a joint production to improve the process efficiency, lower the product unitary cost and obtain the necessary supply for their own demand or that of other countries in need
Subject(s)
Full text: 1 Index: LILACS Main subject: Antivenins / Drug Costs / Public Sector Type of study: Health_economic_evaluation Limits: Humans Language: En Journal: J. venom. anim. toxins incl. trop. dis Journal subject: TOXICOLOGIA Year: 2006 Type: Article
Full text: 1 Index: LILACS Main subject: Antivenins / Drug Costs / Public Sector Type of study: Health_economic_evaluation Limits: Humans Language: En Journal: J. venom. anim. toxins incl. trop. dis Journal subject: TOXICOLOGIA Year: 2006 Type: Article